Welsbach Technology Metals Acquisition Corp. Announces Pricing of $75 Million Initial Public Offering

Written by Customer Service on December 27, 2021. Posted in Public Companies.

New York, NY, Dec. 27, 2021 (GLOBE NEWSWIRE) — Welsbach Technology Metals Acquisition Corp. (the “Company”) announced today that it priced its initial public offering of 7,500,000 units, at $10.00 per unit. The units will be listed on the Nasdaq Global Market (“Nasdaq”) and will begin trading tomorrow, Tuesday, December 28, 2021, under the ticker symbol “WTMAU.” Each unit consists of one share of the Company’s common stock and one right to receive one-tenth (1/10) of a share of common stock upon the consummation of an initial business combination. Once the securities comprising the units begin separate trading, the shares of common stock and rights are expected to be listed on Nasdaq under the symbols “WTMA” and “WTMAR,” respectively. The offering is expected to close on December 30, 2021, subject to customary closing conditions. The...

UFP Industries acquires Ultra Aluminum Manufacturing, expanding its fence and railing offerings

Written by Customer Service on December 27, 2021. Posted in Mergers And Acquisitions.

GRAND RAPIDS, Mich., Dec. 27, 2021 (GLOBE NEWSWIRE) — UFP Industries (Nasdaq: UFPI) today announced that its subsidiary, Deckorators, Inc., has acquired Ultra Aluminum Manufacturing Inc. (Ultra), a leading manufacturer of aluminum fencing, gates and railing, for $25 million. The transaction includes $2 million to be paid if certain future performance goals are met. Founded in 1996 and based in Howell, Michigan, Ultra designs and produces an extensive selection of ornamental aluminum fence and railing products for contractors, landscapers, fence dealers and wholesalers. The company had trailing 12-month sales through November 2021 of approximately $46 million. Ultra President Russ Springborn and Vice President of Business Development Dave Stewart will continue in leadership roles. “This transaction adds aluminum fencing to our current...

Eledon Pharmaceuticals to Participate in January 2022 Investor Conferences

Written by Customer Service on December 27, 2021. Posted in Public Companies.

IRVINE, Calif., Dec. 27, 2021 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a patient-focused clinical stage biopharmaceutical company committed to the development of innovative and impactful treatments for organ and cell transplantation, autoimmune conditions, and neurodegenerative disease, today announced that members of management will be participating in two upcoming virtual investor conferences: Event: LifeSci Partners Corporate Access Event (January 5-7, 2022) Format: 1×1 Meetings To register for the LifeSci Partners Corporate Access Event, please use the following link: here. Event: H.C. Wainwright BIOCNNECT Virtual Conference (January 10-13, 2022) Format: Available on Demand Presentation for registered attendees via the H.C. Wainwright site and 1×1 Meetings If...

Conn’s Summary Notice of Proposed Settlement of Stockholder Derivative Action

Written by Customer Service on December 27, 2021. Posted in Public Companies.

THE WOODLANDS, Texas, Dec. 27, 2021 (GLOBE NEWSWIRE) — The following is being released by Conn’s, Inc. pursuant to an Order of the United States District Court of the Southern District of Texas, Houston Division. This press release relates to the proposed settlement of litigation that was filed in 2014 and captioned: Robert Hack, derivatively on behalf of Conn’s Inc. v. Theodore M. Wright, et al., Civil Action No. 4:14-CV-3442 (KPE); In the United States District Court of the Southern District of Texas, Houston Division SUMMARY NOTICE OF PROPOSED SETTLEMENT OF STOCKHOLDER DERIVATIVE ACTION The United States District Court for the Southern District of Texas authorized this Notice.This is not a solicitation from an attorney TO: ALL RECORD HOLDERS AND BENEFICIAL OWNERS OF CONN’S, INC. (“CONN’S”) COMMON STOCK (TICKER SYMBOL: CONN)...

Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date December 15, 2021

Written by Customer Service on December 27, 2021. Posted in Public Companies.

Nasdaq Short Interest Days Nasdaq Short Interest Days NEW YORK, Dec. 27, 2021 (GLOBE NEWSWIRE) — At the end of the settlement date of December 15, 2021, short interest in 3,103 Nasdaq Global MarketSM securities totaled 8,912,688,445 shares compared with 8,555,941,286 shares in 3,036 Global Market issues reported for the prior settlement date of November 30, 2021. The mid-December short interest represents 2.40 days compared with 2.46 days for the prior reporting period. Short interest in 2,107 securities on The Nasdaq Capital MarketSM totaled 2,337,458,762 shares at the end of the settlement date of December 15, 2021 compared with 2,263,829,860 shares in 2,118 securities for the previous reporting period. This represents a 1.58 day average daily volume; the previous reporting period’s figure was 1.29. In summary,...

A YEAR END LETTER TO SHAREHOLDERS FROM THE CEO OF HCMC

Written by Customer Service on December 27, 2021. Posted in Public Companies.

HOLLYWOOD, FL, Dec. 27, 2021 (GLOBE NEWSWIRE) — Healthier Choices Management Corp. (“HCMC” or the “Company”) (OTC Pink: HCMC) today released a year-end letter from Jeffrey Holman, its CEO, to the Company’s shareholders. The letter follows below and can also be accessed from the Company’s website at www.HealthierCMC.com. December 27, 2021 Dear Valued Shareholders, As the end of a very tumultuous year closes, I wanted to take a moment to thank all of our valued shareholders and reiterate some of the things that we hope to accomplish in 2022. As always, one of our primary goals is to enhance shareholder value. We recognize that at year end many investors strategically sell shares of stocks to take year-end losses for tax purposes. This is an inevitable function of the market and our Company’s stock...

Infant Bacterial Therapeutics today announces new patent protection approvals in Brazil and in Hong Kong

Written by Customer Service on December 27, 2021. Posted in Public Companies.

Infant Bacterial Therapeutics AB today announces that the Patent Offices of Brazil and Hong Kong have approved a patent of Lactobacillus reuteri covering IBP-9414. IBT is currently developing its drug candidate IBP-9414 in Phase III for the prevention of necrotizing colitis and improvement of feeding tolerance in preterm infants. The patent covers a novel way to activate the bacteria. Corresponding patent applications are currently pending across several important future markets. This patent reinforces the existing protection of IBT’s drug candidate IBP-9414. Additional market protection, beyond patent exclusivity, is also anticipated in the form of Orphan Drug Exclusivity and biological data protection in the US and EU. The patent provides coverage until 2036. IBP-9414 is intended to be marketed in Brazil and Hong Kong upon marketing...

ARMOUR Residential REIT, Inc. Announces Guidance For January 2022 Dividend Rate Per Common Share

Written by Customer Service on December 27, 2021. Posted in Dividend Reports And Estimates.

VERO BEACH, Fla., Dec. 27, 2021 (GLOBE NEWSWIRE) — ARMOUR Residential REIT, Inc. (NYSE: ARR and ARR-PRC) (“ARMOUR” or the “Company”) today announced guidance on the January 2022 cash dividend for the Company’s Common Stock, which maintains the current monthly dividend rate of $0.10 per Common share. January 2022 Common Stock Dividend Information Month Dividend Holder of Record Date Payment Date January 2022 $0.10 January 18, 2022 January 28, 2022 Certain Tax Matters ARMOUR has elected to be taxed as a real estate investment trust (“REIT”) for U.S. Federal income tax purposes. In order to maintain this tax status, ARMOUR is required to timely distribute substantially all of its ordinary REIT taxable income. Dividends paid in excess of current tax earnings and profits for the year will generally not be taxable...

ADDvantage Technologies Reports 61% Revenue Growth for the Fourth Quarter of Fiscal 2021

Written by Customer Service on December 27, 2021. Posted in Earnings Releases And Operating Results.

5G-Related Growth in Wireless Segment, Combined with Continued Telco Strength, Drives Robust Top-Line Growth CARROLLTON, Texas, Dec. 27, 2021 (GLOBE NEWSWIRE) — ADDvantage Technologies Group, Inc. (NASDAQ: AEY) (“ADDvantage Technologies” or the “Company”) today reported record revenues for the three and 12 months ended September 30, 2021. “As planned, 5G services activity is surging translating to revenue, as our Wireless segment grew 69% sequentially and 47% year-over-year in the fourth quarter, reaching $7.0 million,” commented Joe Hart, Chief Executive Officer. “This growth is broad-based, representing contracts from several large carriers in various regions, reinforcing our confidence that the 5G buildout is now underway in earnest and ADDvantage Technologies is strategically well-positioned to benefit from this secular, multi-year...

Concentrix Closes Acquisition of PK

Written by Customer Service on December 27, 2021. Posted in Mergers And Acquisitions.

FREMONT, Calif., Dec. 27, 2021 (GLOBE NEWSWIRE) — Concentrix Corporation (Nasdaq: CNXC), a leading global provider of customer experience (CX) services and technologies, today announced that it has closed its recently announced acquisition of PK, and the integration process is underway. This transaction marks Concentrix’ first acquisition since becoming a publicly traded company. PK is a leading global CX digital design and engineering firm with over 5,000 staff across 20 cities in four countries. PK has been recognized and awarded worldwide for designing and engineering digital experiences at scale. The acquisition supports Concentrix’ strategy of investing in digital transformation to deliver exceptional customer experiences and will further the company’s ability to scale digital capabilities faster while building excellence...

Day: December 27, 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice